Merck Inks Pact with Four Generic Drugmakers in India for HIV Drug

Merck inks pact with four generic drugmakers in India for HIV drug

It has also signed such agreements with three other companies in sub-Saharan Africa.

Merck licenses experimental HIV pill to generic makers in 129 countries

Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell lower-cost versions of its experimental once-monthly oral HIV pill in 129 low- and lower-middle-income countries. The drug, alimatravir, is currently in late-stage development. Merck said it is investing early in its product manufacturing capacity as trials continue. Merck said the agreements are with three sub-Saharan Africa manu…